Listening to the voice of the patient early in the course of drug or device …
FDA’s Draft Guidance on Patient-centricity
Patients are the pharmaceutical industry’s raison d’etre. New FDA draft guidance is designed to help …
Advocacy Groups & Patient Engagement
Rare diseases are an area of intense focus for pharmaceutical R&D, but smaller patient populations …
Deeper Understanding Delivers Greater Value
“Know your patient. Deliver real value.” That was the message industry leaders heard at the …
Patients open doors to new opportunities
Preclinical research indicates what a new compound should do. Ideally, clinical studies confirm it. But …